15
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Seronegative conversion after incomplete benznidazole treatment in chronic Chagas disease.

      Transactions of the Royal Society of Tropical Medicine and Hygiene
      Adult, Chagas Disease, blood, drug therapy, Chronic Disease, Drug Administration Schedule, Female, Humans, Male, Nitroimidazoles, administration & dosage, adverse effects, Trypanocidal Agents, Trypanosoma cruzi, drug effects

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In 12-18% of adult patients, treatment with benznidazole for chronic Chagas disease has to be discontinued because of side-effects. We identified and analysed a cohort of 81 adult patients with three positive tests for Trypanosoma cruzi infection and serological monitoring following incomplete treatment with benznidazole for a median of 10 days. Twenty percent of these patients (16/81) met the criteria of cure, showing that the optimal schedule of benznidazole administration remains to be determined. Copyright © 2012 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.

          Related collections

          Author and article information

          Comments

          Comment on this article